New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
10:04 EDTALBAlbermarle says sees weaker 1H13 vs. either half of 2012
Comment made on the Q4 earnings conference call.
News For ALB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
10:49 EDTALBAlbemarle slides after giving guidance on earnings call
Share of specialty chemicals company Albemarle (ALB) are sharply lower and continuing to slide as its fourth quarter earnings call continues. Last night, the company reported Q4 adjusted EPS and revenue that missed analysts' consensus expectations. On its call this morning, the company said that its resources will be directed towards maximizing the potential of its four core businesses, namely lithium, catalyst, surface treatment and bromine, and it will pursue strategic alternatives for its three other businesses. The company said it will launch its sale process for its non-core businesses in February, with a goal of closing transactions by year end. Albemarle guided toward FY15 revenue of $3.7B-$4B, versus the consensus view of $4.22B. Albemarle said it sees FY15 EPS of $3.15-$3.70. Consensus for FY15 EPS prior to the call stood at $4.95. The company also said it sees potential for "both upside or downside" to its FY15 forecasts, depending on how currency plays out. Albemarle shares are down nearly 12% to $48.72 in morning trading as its earning call continues.
10:39 EDTALBAlbemarle drops 7% after guidance issued on Q4 earning conference call
Subscribe for More Information
10:39 EDTALBAlbemarle sees FY15 EPS $3.15-$3.70, may not compare to consensus $4.95
Subscribe for More Information
10:16 EDTALBAlbemarle says to pursue strategic alternatives for non-core businesses
Subscribe for More Information
January 28, 2015
17:21 EDTALBAlbemarle reports Q4 adjusted EPS 99c, consensus $1.03
Subscribe for More Information
January 20, 2015
07:52 EDTALBAlbemarle announces new organizational structure and senior leadership team
Albemarle announced that as a result of the completion of its acquisition of Rockwood Holdings, it will realign its global business units, effective by the end of the Q1. The new structure aligns the company's strategic assets and businesses to be market focused. The new Albemarle structure will consist of three global business units, or GBUs: Chemetall Surface Treatment, Refining Solutions and Performance Chemicals. Consistent with the new organizational structure, the company also announced its senior leadership team, all reporting to President and CEO Luke Kissam. Joris Merckx will serve as president, Chemetall Surface Treatment. Silvio Ghyoot will serve as president, Refining Solutions. Michael Wilson will serve as president, Performance Chemicals. Matt Juneau will serve as senior vice president, Corporate Strategy and Investor Relations. The leadership team changes will become effective with the realignment of the global business units before the end of the Q1. In the interim, business and investor questions should be routed to the current contact.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use